[Surgical Treatment for Thymoma with Good's Syndrome;Report of a Case].

Kyobu Geka

Department of Thoracic Surgery, Tokorozawa Central Hospital, Tokorozawa, Japan.

Published: November 2019

A 50-year-old man was admitted to our hospital for severe pneumonia. An anterior mediastinum tumor and the hypogammaglobulinaemia were detected during treatment of pneumonia, and Good's syndrome was diagnosed. The clinical characteristics of Good's syndrome are increased susceptibility to bacterial infections and opportunistic viral and fungal infections. We planned thymectomy with the perioperative supplementation of immunoganmmagloblin to prevent perioperative infectious complications after pneumonia recovered completely. Extended thymo-thymectomy was performed. Pathological examination revealed type AB thymoma. The hypogammaglobulinaemia did not improved following thymectomy, and the patient had to be treated by immunoglobulin supplementation to maintain adequate trough immunoglobulin G( IgG) values.

Download full-text PDF

Source

Publication Analysis

Top Keywords

good's syndrome
8
[surgical treatment
4
treatment thymoma
4
thymoma good's
4
good's syndromereport
4
syndromereport case]
4
case] 50-year-old
4
50-year-old man
4
man admitted
4
admitted hospital
4

Similar Publications

This case report highlights the diagnostic and therapeutic complexities faced by a 56-year-old female with Good's syndrome (GS), who presented with persistent Coronavirus Disease 2019 (COVID-19) infection alongside spp, , and co-infection, which collectively contributed to severe pulmonary involvement. The report further emphasizes a multifaceted treatment approach, incorporating antivirals, antifungals, antimicrobials, immunoglobulins, and antifibrotic therapy, which ultimately led to an improvement in the patient's condition. It underscored the intricate challenges of managing immunocompromised patients with multiple concurrent infections.

View Article and Find Full Text PDF

A rare case of diarrhea with a rare cause.

Gastroenterology

December 2024

Department of Gastroenterology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China. Electronic address:

View Article and Find Full Text PDF

Persistent COVID-19 improved with immunoglobulin replacement therapy in Good's syndrome.

Respir Investig

January 2025

Department of Respiratory Medicine, Kyoto Katsura Hospital, 17 Yamadahirao-cho, Nishikyo-ku, Kyoto, 615-8256, Japan.

A 69-year-old man with a history of thymoma resection was diagnosed with COVID-19 pneumonia. Initially, the patient responded well to molnupiravir, but he experienced a relapse. Subsequent steroids for COVID-19-related organizing pneumonia (OP) led to temporary improvement, but his condition deteriorated when the steroids were tapered off.

View Article and Find Full Text PDF

Long-standing COVID-19 Disease in Immunocompromised and Immunocompetent Patients; Case Reports and Literature Review.

Iran J Allergy Asthma Immunol

July 2024

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Article Synopsis
  • Patients with immunodeficiency are at a higher risk for severe outcomes from SARS-CoV-2 compared to healthy individuals.
  • A study evaluated immune responses in various immunocompromised patients, showing they had significantly lower T-cell and B-cell responses to the virus compared to healthy controls.
  • The findings highlight the importance of additional precautions for immunocompromised patients to protect them from COVID-19 due to their reduced immune function.
View Article and Find Full Text PDF

Good's syndrome is a rare secondary immunodeficiency characterised by recurrent infection and hypogammaglobulinemia associated with thymus tumour, and symptoms of recurrent infection may persist even after thymectomy. It is characterised by increased susceptibility to bacterial, viral, and fungal infections, as well as autoimmunity. Immunoglobulin replacement therapy has been reported to decrease infection rate, hospitalization, and the rate of antibiotic use in these patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!